- Title: Subtitle
- Reply to IF Tannock, P. Isaacsson Velho et al, RZ Szmulewitz et al, M. Tiako Meyo et al, and FJSH Woei-A-Jin et al
- Creators
- Jill M. Kolesar - University of KentuckyGlenn Liu - University of Wisconsin–Madison
- Resource Type
- Letter/Communication
- Publication Details
- Journal of clinical oncology, Vol.36(30), pp.3065-3066
- Publisher
- Amer Soc Clinical Oncology
- DOI
- 10.1200/JCO.2018.79.3208
- PMID
- 30188791
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Number of pages
- 3
- Grant note
- Novartis Pfizer Johnson Johnson; Johnson & Johnson; Johnson & Johnson USA TRACON Pharma; Dexcel Pharma Madison Vaccines
- Language
- English
- Date published
- 10/20/2018
- Academic Unit
- Pharmacy; Pharmaceutical Sciences and Experimental Therapeutics
- Record Identifier
- 9984696542502771
Letter/Communication
Reply to IF Tannock, P. Isaacsson Velho et al, RZ Szmulewitz et al, M. Tiako Meyo et al, and FJSH Woei-A-Jin et al
Journal of clinical oncology, Vol.36(30), pp.3065-3066
10/20/2018
DOI: 10.1200/JCO.2018.79.3208
PMID: 30188791
Abstract
Details
Metrics
14 Record Views